Why partner with STCC
Discover how STCC provides a strategic advantage in cancer translational research for investigators and industry.
Last updated 14 July 2026
Cancer researchers and industry in Singapore face a common challenge — the expertise, data, clinical networks, and institutional relationships needed to move research forward are spread across multiple organisations. Navigating them independently can be time-consuming, complex, and often unclear.
STCC exists to solve that. We remove the barriers that slow translational cancer research — connecting investigators and industry to the right expertise, platforms, and capabilities across Singapore’s cancer research ecosystem.
As Singapore’s nationally coordinated cancer research network, STCC provide a single point of connection and helps identify the right partners, coordinate cross-institution collaborations, and bring together Singapore’s collective strengths in cancer research.
WHAT WE OFFER
STCC's Capabilities & Services
Whether you are an investigator advancing discovery or from industry accelerating innovation, STCC connects you to the expertise, capabilities, collaborations, and clinical pathways needed to move cancer research forward—faster.
Single point of contact with a globally recognised clinical infrastructure
STCC provides a single point of contact with Singapore's cancer research infrastructure — recognised internationally through memberships including the imCORE Network, of which STCC is the first Southeast Asian member.
National centralised oncology specimens catalogue and datasets
STCC's integrated, AI-ready multi-modal data platform combining clinical, specimen and multi-omics data across Singapore’s cancer research community, enabling cohort discovery, research and clinical translation to optimise patient care — governed by a robust end-to-end framework adhering to national and international data security standards.
Highly integrated oncology programmes with robust translational outcomes
STCC's five joint platforms operate as a coordinated national infrastructure — ensuring that clinical trials, databases, translational research, industry partnerships, and population health insights work together rather than in silos.
Strategic academia-industry alliance networks
STCC serves as a strategic partner for leading academia-industry collaborations — facilitating partnerships that advance translational cancer science across Singapore's research ecosystem.
Evidence generation to support policymaking
Through our Impact & Population Health platform, STCC translates cancer research findings into clinical guidelines, health policies, and population health strategies — ensuring scientific advances generate measurable impact.
Ready to make STCC your strategic partner?
Tell us about your research question, trial concept, or partnership interest — and we will connect you to the right people and platforms across Singapore's cancer research ecosystem.